Mycobacterium avium complex disease (MAC) in HIV patients: Incidence and risk factors before and after HAART;Mycobacterium avium complex chez les sujets seropositifs pour le VIH: Incidence et facteurs de risque avant et apres l'introduction des traitements antiretroviraux hautement actifs

Pathologie Biologie

Volumn 48, Issue 5, 2000, Pages 495-504

  Mary Krause, M ^a   Rabaud, C ^a   Jouan, M ^a   Obadia, M ^a   de la Blanchardiere, A ^a   Raffi, F ^a   May, T ^a   Alfandari, S ^a   Bastides, F ^a   Billaud, E ^a   Boibieux, A ^a   Boue, F ^a   Bricaire, F ^a   Costagliola, D ^a   Cotte, L ^a   Cuzin, L ^a   Dabis, F ^a   Fournier, S ^a   Gasnault, J ^a   Gaud, C ^a   Gilquin, J ^a   Grabar, S ^a   Lacoste, D ^a   Lang, J M ^a   Laurichesse, H ^a   Leclercq, P ^a   Leport, C ^a   Matheron, S ^a   Meyohas, M C ^a   Michelet, C ^a   Moreau, J ^a   Pialoux, G ^a   Poizot Martin, I ^a   Pradier, C ^a   Rouveix, E ^a   Saiag, P ^a   Salmon Ceron, D ^a   Soubeyrand, J ^a   Tissot Dupont, H ^a   more..

^a INSERM   (France)

Author keywords

HIV; Incidence; Mycobacterium avium; Prophylaxis; Risk factors

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; RIFABUTIN;

CHEMOPROPHYLAXIS; CONFERENCE PAPER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MYCOBACTERIOSIS; NONHUMAN; RISK FACTOR; T LYMPHOCYTE;

ADULT; ANTI-HIV AGENTS; ANTIBIOTICS, ANTITUBERCULAR; CD4 LYMPHOCYTE COUNT; FEMALE; HIV PROTEASE INHIBITORS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RIFABUTIN; RISK FACTORS;

EID: 0033929729     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)